By Jacob Wolinsky. Originally published at ValueWalk.
Sohn Conference Winner H/T @ChesapeakeCap
SEE THE FULL CONFERENCE HIGHLIGHTS HERE-> LINK
The contest is intended to encourage anyone with an investment idea to showcase that idea in front of the world’s leading global investment minds entries can be any marketable security (long or short) with a market capitalization above $1 billion. The winner will be selected based on the judges’ determination of the most compelling investment idea over a one-year horizon.
A distinguished group of judges led by Joel Greenblatt and including Bill Ackman, David Einhorn, Seth Klarman and Michael Price will determine the most compelling investment idea. The winner will present the investment idea in front of approximately 3,000 people at the renowned Sohn Investment Conference.
WINNER
Marc Grow
FINALISTS
Dan David
Marc Grow
DXCM
Steven Wood
EXO IM
Alex Esparza
UHAL
SEMIFINALISTS
Akiva Stechler
Sana Danish
UHAL
Arthur Baer
CCO
Venkata Amarthaluru
NN NA
Karan Parekh
PTC
Arturo Osorio
KLXI
Duncan Tennant
PYPL
Mike Gorlon
STMP
Sohn Conference Winner – Short Dexcom (DXCM) “Where’s the insulin? DXCM is hyperglycemic.” Slides
Company & Industry Overview
DXCM is a medical device company that develops and manufactures conXnuous glucose monitoring (CGM) systems for type 1 diabetes
Competiton is Coming
Eroding Market Share
§ Medtronic integrated device
§ Developing single inserXon site technology
§ Abbott Labs success in EU with Freestyle Libre
§ Senseonics 90 day implantable device
§ Applied for CE Mark § Expected 2017
Adoption Headwinds
NOT EVERYONE WANTS TO BE PLUGGED INTO A DEVICE
§ “I decided to quit using my CGM because of the hassle of calibraXng [with finger pricks] and the alarms.”
Type 1 pa(ent and former CGM user § “There’s a meaningful populaXon of Type 1s who do not want to be plugged into a device.” –
Nurse Educator NOT EVERYONE CAN OR WANTS TO PAY FOR IT
§ “Many Type 1s follow consistent regiments that allow them to know their levels with li`le variability, CGMs can be used every so ooen for calibraXon” – Former VP of Insulet NOT EVERYONE IS CANDIDATE FOR CGM & PUMP THERAPY
§ “These devices require acXve management and significant training, not everyone is an ideal candidate” – Diabetes America Executive
Sohn Conference Winner
Sohn Conference Winner slides here -> Grow_Short-DXCM
The post Sohn Conference Winner – Short Dexcom (DXCM) Slides appeared first on ValueWalk.
Sign up for ValueWalk’s free newsletter here.
